- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期行情可能回暖，可适量买进股票，作短线反弹行情。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有399家主力机构披露2025-06-30报告期持股数据，持仓量总计4.08亿股，占流通A股67.58%
- 波段诊断：
-
技术面诊股
平均成本
近期的平均成本为177.77元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"177.77","date":1761814817,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，明显跑输行业平均水平。
[{"date":"2025.10.31","stock":"0.64","trade":"2.11","ind":"-0.81"},{"date":"2025.10.30","stock":"-1.02","trade":"-1.13","ind":"-0.73"},{"date":"2025.10.29","stock":"0.35","trade":"-0.32","ind":"0.70"},{"date":"2025.10.28","stock":"0.40","trade":"-0.54","ind":"-0.22"},{"date":"2025.10.27","stock":"-1.79","trade":"-0.12","ind":"1.18"},{"date":"2025.10.24","stock":"-0.42","trade":"-0.63","ind":"0.71"},{"date":"2025.10.23","stock":"0.05","trade":"-0.36","ind":"0.22"},{"date":"2025.10.22","stock":"-2.15","trade":"0.70","ind":"-0.07"},{"date":"2025.10.21","stock":"-0.91","trade":"0.86","ind":"1.36"},{"date":"2025.10.20","stock":"-4.71","trade":"0.20","ind":"0.63"},{"date":"2025.10.17","stock":"-0.48","trade":"-0.94","ind":"-1.95"},{"date":"2025.10.16","stock":"0.98","trade":"0.75","ind":"0.10"},{"date":"2025.10.15","stock":"0.18","trade":"1.37","ind":"1.22"},{"date":"2025.10.14","stock":"0.53","trade":"0.32","ind":"-0.62"},{"date":"2025.10.13","stock":"-1.03","trade":"-0.86","ind":"-0.19"},{"date":"2025.10.10","stock":"-0.11","trade":"1.31","ind":"-0.94"},{"date":"2025.10.09","stock":"-0.29","trade":"0.26","ind":"1.32"},{"date":"2025.09.30","stock":"0.14","trade":"0.12","ind":"0.52"},{"date":"2025.09.29","stock":"0.33","trade":"0.13","ind":"0.90"},{"date":"2025.09.26","stock":"-0.35","trade":"-0.51","ind":"-0.65"},{"date":"2025.09.25","stock":"0.25","trade":"-0.70","ind":"-0.01"}]
片仔癀,上证指数,中药指数
压力支撑
该股压力位为177.09元，支撑位为176.07元。
[{"text":"\u538b\u529b\u4f4d","value":"177.09","date":1761840000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"176.07","date":1761840000,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.5资金面打败了43%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月31日 20:38
| 机构今日流向(万元) | 2960.52 | 机构5日流向(万元) | -2525.32 |
| 机构10日流向(万元) | -5940.49 | 机构20日流向(万元) | -6714.43 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少102.8万股，其中基金净减仓106家，主力净增仓49家，暂未发现中长期投资价值。
截止2025-06-30，共399家主力机构（基金392家，一般法人7家），持仓量总计40772.74万股，占流通A股67.58%
其中，基金持仓与2024-12-31相比：
增仓：59家 ，增持 140.78万股
减仓：165家 ，减持 640.80万股
新出现在主力名单中：132家 ，持有213.11万股
从主力名单中消失：83家 ，原持有69.78万股
其中，基金持仓与2024-12-31相比：
增仓：59家 ，增持 140.78万股
减仓：165家 ，减持 640.80万股
新出现在主力名单中：132家 ，持有213.11万股
从主力名单中消失：83家 ，原持有69.78万股
消息面诊股
诊断结果：5.7消息面打败了56%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 片仔癀：10月30日获融资买入3450.60万元
2025-10-31 - 片仔癀高增长神话破灭，定价逻辑陷死胡同
2025-10-30 - 片仔癀黄芩多肽洗护新品亮相漳州，以东方智慧开启舒缓
2025-10-30 - 片仔癀：10月29日获融资买入8950.96万元
2025-10-30 - 280家医药企业最新营收排名来了！
2025-10-29 - 片仔癀与茅台开启会谈 共商文化传承与创新发展
2025-10-29 - 片仔癀：10月28日获融资买入3406.38万元
2025-10-29 - 片仔癀：以研发创新与产业投资，书写“老字号”成长“
2025-10-28 - 片仔癀价格大跌
2025-10-28 - 林园：人口老龄化将利好中华老字号中药品牌
2025-10-28
消息列表
| 一般消息 | 重大事项 | 关联交易 | 2025-09-29 |
| 一般消息 | 高管变动 | 因工作调整原因 | 2025-09-28 |
| 利好 | 分红转增 | 10派14元(含税) | 2025-08-30 |
| 一般消息 | 高管变动 | 工作调整 | 2025-08-13 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-07 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-07-04 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-31 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-05-30 |
| 利好 | 分红转增 | 10派18.2元(含税) | 2025-04-26 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-26 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-04-08 |
| 一般消息 | 高管变动 | 因工作调整原因 | 2025-01-07 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 0条 | 4条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.2行业面打败了69%的股票
中药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.10.31","price":"-0.81","value":"2.11"},{"date":"2025.10.30","price":"-0.73","value":"-1.13"},{"date":"2025.10.29","price":"0.70","value":"-0.32"},{"date":"2025.10.28","price":"-0.22","value":"-0.54"},{"date":"2025.10.27","price":"1.18","value":"-0.12"},{"date":"2025.10.24","price":"0.71","value":"-0.63"},{"date":"2025.10.23","price":"0.22","value":"-0.36"},{"date":"2025.10.22","price":"-0.07","value":"0.70"},{"date":"2025.10.21","price":"1.36","value":"0.86"},{"date":"2025.10.20","price":"0.63","value":"0.20"},{"date":"2025.10.17","price":"-1.95","value":"-0.94"},{"date":"2025.10.16","price":"0.10","value":"0.75"},{"date":"2025.10.15","price":"1.22","value":"1.37"},{"date":"2025.10.14","price":"-0.62","value":"0.32"},{"date":"2025.10.13","price":"-0.19","value":"-0.86"},{"date":"2025.10.10","price":"-0.94","value":"1.31"},{"date":"2025.10.09","price":"1.32","value":"0.26"},{"date":"2025.09.30","price":"0.52","value":"0.12"},{"date":"2025.09.29","price":"0.90","value":"0.13"},{"date":"2025.09.26","price":"-0.65","value":"-0.51"},{"date":"2025.09.25","price":"-0.01","value":"-0.70"}]
上证指数,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 万邦德 | 40.50% | 6.32% | 6.0分 |
| 2 | 特一药业 | 28.39% | 1.29% | 6.3分 |
| 3 | 以岭药业 | 13.81% | 4.56% | 6.6分 |
| 4 | 吉林敖东 | 13.35% | 4.53% | 5.8分 |
| 5 | 信邦制药 | 11.70% | -0.26% | 5.4分 |
| 6 | 众生药业 | 10.91% | 7.57% | 6.7分 |
| 8 | 粤万年青 | 8.66% | -1.33% | 5.4分 |
| 10 | 马应龙 | 7.30% | 1.22% | 5.4分 |
| 12 | 嘉应制药 | 6.00% | 0.15% | 5.8分 |
| 14 | 莱茵生物 | 5.20% | 2.93% | 6.0分 |
| 16 | 中恒集团 | 4.89% | -0.36% | 5.8分 |
| 18 | 红日药业 | 4.37% | 1.06% | 6.0分 |
| 20 | 佛慈制药 | 4.04% | 0.00% | 5.3分 |
| 22 | 新光药业 | 3.94% | -1.65% | 5.7分 |
| 24 | 白云山 | 3.90% | 2.81% | 6.6分 |
| 26 | 盘龙药业 | 3.23% | -3.37% | 5.8分 |
| 28 | 千金药业 | 2.90% | -0.37% | 6.4分 |
| 30 | 益盛药业 | 2.63% | 0.99% | 5.6分 |
| 32 | 桂林三金 | 2.33% | -1.64% | 5.9分 |
| 34 | 达仁堂 | 2.13% | 4.86% | 5.3分 |
| 36 | 天目药业 | 1.89% | -2.13% | 6.5分 |
| 38 | 康美药业 | 1.48% | 0.98% | 5.9分 |
| 40 | 珍宝岛 | 1.35% | -4.80% | 4.2分 |
| 42 | 九芝堂 | 1.01% | 2.14% | 6.0分 |
| 44 | 汉森制药 | 0.63% | -3.19% | 5.3分 |
| 46 | 东阿阿胶 | 0.25% | -0.75% | 5.1分 |
| 48 | 沃华医药 | 0.16% | -0.16% | 5.8分 |
| 50 | 康惠股份 | -0.36% | -2.19% | 5.3分 |
| 52 | 太龙药业 | -0.46% | -1.68% | 5.3分 |
| 54 | 云南白药 | -1.08% | 0.53% | 5.5分 |
| 56 | 维康药业 | -1.35% | 7.84% | 5.3分 |
| 58 | 天士力 | -1.84% | -1.72% | 5.6分 |
| 60 | 佐力药业 | -2.07% | -3.79% | 4.7分 |
| 62 | 昆药集团 | -2.99% | -2.86% | 4.6分 |
| 64 | 恩威医药 | -4.50% | -1.28% | 4.9分 |
| 66 | 葵花药业 | -5.50% | -6.17% | 4.3分 |
| 68 | ST香雪 | -8.57% | 1.40% | 3.9分 |
| 70 | 片仔癀 | -9.37% | -1.43% | 4.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 7/110 ， 51/110。
[{"date":"2025-09-30","value":"14.82","vol":"4.71"},{"date":"2025-06-30","value":"9.98","vol":"3.94"},{"date":"2025-03-31","value":"6.77","vol":"2.20"},{"date":"2024-12-31","value":"21.54","vol":"4.81"},{"date":"2024-09-30","value":"19.61","vol":"2.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
14.82 | 9.98 | 6.77 | 21.54 | 19.61 |
| 行业(%) | 4.71 | 3.94 | 2.20 | 4.81 | 2.92 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"38.93","vol":"51.91"},{"date":"2025-06-30","value":"40.41","vol":"52.43"},{"date":"2025-03-31","value":"45.05","vol":"52.92"},{"date":"2024-12-31","value":"42.74","vol":"52.40"},{"date":"2024-09-30","value":"45.44","vol":"52.75"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
38.93 | 40.41 | 45.05 | 42.74 | 45.44 |
| 行业(%) | 51.91 | 52.43 | 52.92 | 52.40 | 52.75 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 47/110 ， 46/110。
[{"date":"2025-09-30","value":"-11.93","vol":"-7.07"},{"date":"2025-06-30","value":"-4.81","vol":"-6.98"},{"date":"2025-03-31","value":"-0.92","vol":"-6.63"},{"date":"2024-12-31","value":"7.25","vol":"-6.97"},{"date":"2024-09-30","value":"11.19","vol":"-4.57"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-11.93 | -4.81 | -0.92 | 7.25 | 11.19 |
| 行业(%) | -7.07 | -6.98 | -6.63 | -6.97 | -4.57 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-20.74","vol":"-2.96"},{"date":"2025-06-30","value":"-16.22","vol":"2.33"},{"date":"2025-03-31","value":"2.59","vol":"-36.42"},{"date":"2024-12-31","value":"6.42","vol":"-142.71"},{"date":"2024-09-30","value":"11.73","vol":"63.06"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-20.74 | -16.22 | 2.59 | 6.42 | 11.73 |
| 行业(%) | -2.96 | 2.33 | -36.42 | -142.71 | 63.06 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 20/110 ， 57/110。
[{"date":"2025-09-30","value":"0.43","vol":"0.35"},{"date":"2025-06-30","value":"0.30","vol":"0.24"},{"date":"2025-03-31","value":"0.17","vol":"0.12"},{"date":"2024-12-31","value":"0.62","vol":"0.49"},{"date":"2024-09-30","value":"0.48","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.43 | 0.30 | 0.17 | 0.62 | 0.48 |
| 行业(次) | 0.35 | 0.24 | 0.12 | 0.49 | 0.37 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.82","vol":"1.72"},{"date":"2025-06-30","value":"0.60","vol":"1.17"},{"date":"2025-03-31","value":"0.35","vol":"0.60"},{"date":"2024-12-31","value":"1.48","vol":"2.40"},{"date":"2024-09-30","value":"1.16","vol":"1.79"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.82 | 0.60 | 0.35 | 1.48 | 1.16 |
| 行业(次) | 1.72 | 1.17 | 0.60 | 2.40 | 1.79 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"5.39","vol":"9.52"},{"date":"2025-06-30","value":"-24.16","vol":"20.17"},{"date":"2025-03-31","value":"29.16","vol":"0.38"},{"date":"2024-12-31","value":"0.63","vol":"15.45"},{"date":"2024-09-30","value":"32.77","vol":"6.15"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 5.39 | -24.16 | 29.16 | 0.63 | 32.77 |
| 行业 | 9.52 | 20.17 | 0.38 | 15.45 | 6.15 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"2.43","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"10.22","vol":"1.46"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 2.43 | - | 10.22 | - |
| 行业 | 0.00 | 1.02 | 0.00 | 1.46 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 60/110 ， 9/110。
[{"date":"2025-09-30","value":"5.00","vol":"3.03"},{"date":"2025-06-30","value":"3.84","vol":"2.88"},{"date":"2025-03-31","value":"5.24","vol":"2.97"},{"date":"2024-12-31","value":"4.77","vol":"2.86"},{"date":"2024-09-30","value":"5.12","vol":"3.22"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
5.00 | 3.84 | 5.24 | 4.77 | 5.12 |
| 行业 | 3.03 | 2.88 | 2.97 | 2.86 | 3.22 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.15","vol":"2.19"},{"date":"2025-06-30","value":"0.92","vol":"2.11"},{"date":"2025-03-31","value":"1.06","vol":"2.20"},{"date":"2024-12-31","value":"1.03","vol":"2.09"},{"date":"2024-09-30","value":"1.36","vol":"2.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.15 | 0.92 | 1.06 | 1.03 | 1.36 |
| 行业 | 2.19 | 2.11 | 2.20 | 2.09 | 2.40 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 60/110 ， 59/110。
[{"date":"2025-09-30","value":"13.95","vol":"33.17"},{"date":"2025-06-30","value":"18.77","vol":"33.91"},{"date":"2025-03-31","value":"14.29","vol":"33.34"},{"date":"2024-12-31","value":"15.40","vol":"34.08"},{"date":"2024-09-30","value":"18.82","vol":"32.93"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
13.95 | 18.77 | 14.29 | 15.40 | 18.82 |
| 行业(%) | 33.17 | 33.91 | 33.34 | 34.08 | 32.93 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.17","vol":"0.74"},{"date":"2025-06-30","value":"0.24","vol":"0.74"},{"date":"2025-03-31","value":"0.17","vol":"0.72"},{"date":"2024-12-31","value":"0.19","vol":"0.74"},{"date":"2024-09-30","value":"0.24","vol":"3.16"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.17 | 0.24 | 0.17 | 0.19 | 0.24 |
| 行业(%) | 0.74 | 0.74 | 0.72 | 0.74 | 3.16 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以增持为主，认为该股票有一定投资价值。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2025-10-27 | 增持 | 增持 |
| 国投证券 | 2025-10-23 | 增持 | |
| 浙商证券 | 2025-10-20 | 买入 | |
| 华兴证券 | 2025-09-18 | 增持 | |
| 华泰金融(HK) | 2025-09-16 | 增持 | |
| 华泰证券 | 2025-09-16 | 增持 | 增持 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"24.31","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"24.72","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"27.97","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"29.77","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"30.00","blueLineValue":"4.97","type":"YC"}]